Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lunit Backs the Potential of Tertiary Lymphoid Structures Analysis as an Emerging Biomarker for Lung Cancer Treatment - to be presented at WCLC 2023 2023-08-21 21:00
YGF Inc. Launches New Product Developed With 'Fire Evacuation Mask' Patent Technology 2023-08-21 20:00
CanariaBio Achieves Significant Milestone with FDA's Orphan Drug Designation for MAb-AR20.5 Targeting Pancreatic Cancer 2023-08-21 20:00
Zepp Health Corporation Reports Second Quarter 2023 Unaudited Financial Results 2023-08-21 18:15
So-Young Reports Unaudited Second Quarter 2023 Financial Results 2023-08-21 17:30
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination 2023-08-19 04:30
Boryung Partners with AIAA to Host 'Humans In Space Symposium' at 2023 ASCEND 2023-08-19 01:00
World Leading Rehabilitation Expert Prof. Dr. Christopher Gutenbrunner Visits Siyi Intelligence 2023-08-18 21:00
Inmagene's anti-OX40 mAb demonstrated an extended half-life and a favorable safety profile in a Phase I study 2023-08-18 19:00
Nature-inspired pressure sensing technology aims to transform healthcare and surgical robots 2023-08-18 17:54
United Imaging Healthcare delivers its 2023 Half-Year report, with revenue growth of 26.35% in the first half of 2023 2023-08-18 17:29
JinMed (NASDAQ: ZJYL) Rings the Nasdaq Stock Market Closing Bell on August 17 2023-08-18 11:36
Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements. 2023-08-18 08:58
The Global Medical Robotics Conference 2023: A Deep Dive into China's Booming Surgical Robotics Landscape 2023-08-18 02:08
Neurophth Announces First Patient Dosed in Phase I/II Clinical Trial of Second Gene Therapy 2023-08-17 21:00
Minghui Pharmaceutical Inc. Announces First Patient Enrollment in the Phase 3 Clinical Study of MH004 Cream for Treatment of Mild to Moderate Atopic Dermatitis 2023-08-17 19:00
I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates 2023-08-17 18:00
2023WCLC Oral Presentation | Molecular Analysis Validates the Effectiveness of Tumor Tissue-Based and Plasma ctDNA Testing in Identifying NSCLC Patients with EGFR Exon20ins Eligible for Treatment with Sunvozertinib 2023-08-17 17:10
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency 2023-08-16 01:00
1 80 81 82 83 84 800